Jazz Pharma Plc (JAZZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Sales | 897,800 | 1,088,173 | 1,054,969 | 1,023,825 | 901,983 |
| Cost of Goods | 104,600 | 128,713 | 111,611 | 109,902 | 95,487 |
| Gross Profit | 793,200 | 959,460 | 943,358 | 913,923 | 806,496 |
| Operating Expenses | 849,700 | 769,403 | 683,759 | 715,382 | 740,776 |
| Operating Income | -55,900 | 190,770 | 260,210 | 199,443 | 66,207 |
| Interest Expense | 53,700 | 51,256 | 58,702 | 62,023 | 66,116 |
| Other Income | -700 | -6,311 | -986 | 495 | -3,040 |
| Pre-tax Income | -110,300 | 133,203 | 200,522 | 137,915 | -2,949 |
| Income Tax | -17,800 | -57,912 | -14,533 | -30,653 | 11,669 |
| Net Income Continuous | -92,500 | 191,115 | 215,055 | 168,568 | -14,618 |
| Net Income | $-92,500 | $191,115 | $215,055 | $168,568 | $-14,618 |
| EPS Basic Total Ops | -1.52 | 3.11 | 3.50 | 2.68 | -0.23 |
| EPS Basic Continuous Ops | -1.52 | 3.11 | 3.50 | 2.68 | -0.23 |
| EPS Diluted Total Ops | -1.52 | 2.97 | 3.42 | 2.49 | -0.23 |
| EPS Diluted Continuous Ops | -1.52 | 2.89 | 3.40 | 2.42 | -0.23 |
| EPS Diluted Before Non-Recurring Items | 0.60 | 5.70 | 5.86 | 4.67 | N/A |
| EBITDA(a) | $108,900 | $359,187 | $425,442 | $362,478 | $229,590 |